Over 60 years of life-saving research and humane animal care
Ei Terasawa, professor of pediatrics in the UW–Madison School of Medicine and Public Health (SMPH), learned this August that she had earned emeritus status from the University of Wisconsin–Madison. She may have 53 years at UW–Madison and the Wisconsin National Primate Research Center behind her, but she shows no signs of slowing down. Terasawa had …
The Wisconsin National Primate Research Center is proud to share that Dr. Toni Ziegler will be honored with the Midwest Primate Interest Group (MPIG) Distinguished Primatologist Award at the 23rd Annual MPIG Meeting, taking place October 2-3, 2026, at the University of Notre Dame. A Distinguished Scientist Emeritus at the Wisconsin National Primate Research Center, …
Join us for a day of discovery at the Marmoset Lobby! Date: Saturday, October 17, 2026 Time: 10am-2pm Where: 1220 Capitol Court, Madison, WI 53705.
Science Translational Medicine chose this article about vaccine design for Shigella as their featured article in September.
When illness strikes, white blood cells are the first cells on the scene. Much like a team of superheroes they each complete their specialized task, engulfing bacteria, controlling the immune response, and cleaning up dead or damaged cells. Leading the charge, is the macrophage, which literally translates to “big eater”. These white blood cells destroy …
After more than three decades of groundbreaking research, mentorship, and leadership at UW–Madison and the WNPRC, David Abbott, PhD has retired leaving behind a legacy in reproductive science. This interview reflects on Abbott’s contributions to Polyendocrine Metabolic Ovary Syndrome (PMOS, formerly known as Polycystic Ovary Syndrome or PCOS), his students and trainees, and a career …
Congenital heart defects are the most common type of birth defect in the United States and can result in heart failure early in life. Stem cell grafts offer potential as a treatment for cardiac defects, but both laboratory bench experiments and whole-animal studies are necessary for progress in this area. By testing cardiac treatments in …
A new investigational treatment for Parkinson’s disease is showing early promise in its first human clinical trial, thanks in part to foundational work at the University of Wisconsin–Madison and the Wisconsin National Primate Research Center (WNPRC).
Even babies born without the virus’s notable physical symptoms may experience sensory, attachment and anxiety issues, according to a new study.